CECR2 and breast carcinoma: Pharmacological inhibition of the acetyl-lysine reader, cat eye syndrome chromosome region candidate 2 (CECR2), has been found to impede macrophage-mediated NF-κB immunosuppression and to inhibit breast cancer metastasis (41).